MATERNAL EXPOSURE DURING PREGNANCY

This adverse event was reported 89222 times

These drugs are most commonly taken by patients reporting MATERNAL EXPOSURE DURING PREGNANCY:

# Drug Count
0 FOLIC ACID 8766
1 ADALIMUMAB 8694
2 PREDNISONE 8481
3 METHOTREXATE SODIUM 7211
4 INFLIXIMAB 7092
5 METHOTREXATE 6792
6 RITUXIMAB 6758
7 LEFLUNOMIDE 6593
8 CETIRIZINE HYDROCHLORIDE 6485
9 TOCILIZUMAB 6434
See all common drugs associated with MATERNAL EXPOSURE DURING PREGNANCY

MATERNAL EXPOSURE DURING PREGNANCY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PSEUDOEPHEDRINE HCL 3900 0.3563
1 CORTISONE ACETATE 4426 0.3541
2 CAFFEINE CITRATE 719 0.3081
3 DESOXIMETASONE 5400 0.2802
4 TOFACITINIB CITRATE 2453 0.1830
5 METHYLDOPA 838 0.1698
6 DICLOFENAC POTASSIUM 1781 0.1611
7 CETIRIZINE HYDROCHLORIDE TABLETS 4864 0.1550
8 GOLIMUMAB 1952 0.1550
9 OXYTOCIN 441 0.1448
See all drugs enriched for association with MATERNAL EXPOSURE DURING PREGNANCY

MATERNAL EXPOSURE DURING PREGNANCY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1026 1.4913
1 Oxytocic [EPC] 441 0.1447
2 Endoglycosidase [EPC] 251 0.1355
3 Provitamin D2 Compound [EPC] 3208 0.1078
4 Interleukin-17A Antagonist [EPC] 4003 0.1074
5 Antirheumatic Agent [EPC] 6604 0.0624
6 Aminosalicylate [EPC] 6213 0.0617
7 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 522 0.0598
8 alpha-1 Adrenergic Agonist [EPC] 221 0.0498
9 Interleukin-6 Receptor Antagonist [EPC] 6622 0.0478
See all drug classes enriched for association with MATERNAL EXPOSURE DURING PREGNANCY